Browse/search for people

Publication - Dr Katy Turner

    An early evaluation of clinical and economic costs and benefits of implementing point of care NAAT tests for Chlamydia trachomatis and Neisseria gonorrhoea in genitourinary medicine clinics in England

    Citation

    Turner, KME, Round, JA, Horner, PJ, Macleod, JAA, Goldenberg, S, Deol, A & Adams, EJ, 2013, ‘An early evaluation of clinical and economic costs and benefits of implementing point of care NAAT tests for Chlamydia trachomatis and Neisseria gonorrhoea in genitourinary medicine clinics in England’. Sexually Transmitted Infections, vol 90., pp. 104-111

    Abstract

    To estimate the costs and benefits of clinical pathways incorporating a point of care (POC) nucleic acid amplification test (NAAT) for chlamydia and gonorrhoea in genitourinary medicine (GUM) clinics compared with standard off-site laboratory testing.

    Full details in the University publications repository